Back to MDCO Stock Lookup
Pages: 1 2 »» Last Page

MDCO – Analyst Ratings

Apr 17, 2014 07:08 AM Leerink Swann Downgrades The Medicines Company (MDCO) to Market Perform
Apr 2, 2014 06:43 AM Piper Jaffray Downgrades The Medicines Company (MDCO) to Neutral
Apr 1, 2014 07:30 AM Credit Suisse Cuts The Medicines Co. (MDCO) PT to $28 Following Hospira Patent Litigation Outcome
Apr 1, 2014 06:52 AM The Medicines Company (MDCO) Angiomax Patent Case Worst-Case Scenario Suggests $19 Fair Value, Jefferies Says
Feb 13, 2014 07:39 AM UPDATE: Jefferies Downgrade The Medicines Company (MDCO) to Hold as FDA Panel Votes Against Cangrelor
Feb 13, 2014 07:25 AM Credit Suisse Downgrades The Medicines Company (MDCO) to Neutral
Feb 10, 2014 11:21 AM Cangrelo Will be Commercial Failure Even if FDA Approved - Analyst (MDCO)
Aug 15, 2013 07:27 AM BofA/Merrill Lynch Upgrades The Medicines Company (MDCO) to Buy
Jul 12, 2013 01:36 PM Medicines (MDCO) Investors Overreacting, Says RBC
Jun 20, 2013 04:23 PM Oppenheimer Assumes/ Downgrades The Medicines Company (MDCO) to Perform
Jun 5, 2013 04:15 PM Piper Jaffray Starts The Medicines Company (MDCO) at Overweight
Apr 25, 2013 10:30 AM Jefferies Lifts Numbers on The Medicines Company (MDCO)
Mar 27, 2013 06:48 AM Guggenheim Starts The Medicines Company (MDCO) at Buy
Mar 15, 2013 07:45 AM Credit Suisse Starts The Medicines Company (MDCO) at Outperform
Feb 21, 2013 12:17 PM Jefferies Cuts Estimates But Lifts PT on The Medicines Co (MDCO) Post Q4
Feb 4, 2013 03:02 PM Needham & Company Boosts Alnylam (ALNY) PT to $28 on Medicines Co. Deal
Jan 9, 2013 10:00 AM Oppenheimer Comments on Medicines' (MDCO) Cangrelor Trial
Jan 3, 2013 08:50 AM ISI Group Starts The Medicines Company (MDCO) at Buy
Dec 20, 2012 01:33 PM SOLO-1 Data 'Solidifies' Medicines (MDCO) as M&A Target, Partner Candidate
Dec 20, 2012 10:09 AM JPMorgan Upgrades The Medicines Company (MDCO) to Overweight
Nov 20, 2012 07:11 AM Oppenheimer Starts The Medicines Company (MDCO) at Outperform
Oct 16, 2012 06:44 AM Jefferies Upgrades The Medicines Company (MDCO) to Buy, Attractive Reward/Risk
Aug 22, 2012 08:38 AM BofA/Merrill Lynch Starts The Medicines Company (MDCO) at Neutral
Aug 8, 2012 03:17 PM WallachBeth Capital Starts The Medicines Company (MDCO) at Buy
Apr 26, 2012 10:49 AM Auriga Reiterates a 'Buy' on The Medicines Company (MDCO); Continues to make progress on all front
Feb 23, 2012 02:03 PM Auriga Reiterates a 'Buy' on The Medicines Company (MDCO); Believe the Company is Well Positioned
Dec 21, 2011 07:27 AM Jefferies Starts The Medicines Company (MDCO) at Hold
Nov 30, 2011 07:55 AM Auriga Starts The Medicines Company (MDCO) at Buy
Aug 8, 2011 07:21 AM Citadel Securities Starts The Medicines Company (MDCO) at Add; Positive Resolution for Angiomax Patent Battle Expected
Jun 9, 2011 09:27 AM Argus Upgrades The Medicines Company (MDCO) to Buy
Oct 7, 2010 08:49 AM RBC Capital Downgrades Medicines Co. (MDCO) to Sector Perform
Sep 10, 2010 11:14 AM Wedbush Maintains a 'Neutral' on The Medicines Co (MDCO); Solicitor General Not to Appeal �At This Time�
Aug 4, 2010 10:18 AM Citi Maintains a 'Buy' on The Medicines Company (MDCO); Wins Patent Extension Ruling
Jul 16, 2010 08:18 AM Capstone Investments Initiates Coverage on The Medicines Company (MDCO) with a Buy
Jul 7, 2010 12:42 PM Citi 2Q10 SMID Biotech Earnings Preview: Adjusting AUXL & DNDN Models Ahead of Earnings; Top-Pick is BioMarin (BMRN)
May 26, 2010 09:28 AM RBC Capital Upgrades The Medicines Co. (MDCO) to Outperform
Mar 23, 2010 09:32 AM Wedbush Maintains an 'Underperform' on The Medicines Company (MDCO); Recent PTO Ruling Lowers Chance of Angiomax Patent Extension
Sep 15, 2009 09:32 AM Wedbush Morgan Downgrades The Medicines Company (MDCO) to Underperform
Jul 30, 2009 09:08 AM UBS Downgrades The Medicines Company (MDCO) to Neutral
May 13, 2009 02:13 PM Wedbush Morgan Upgrades Medicines Co. (MDCO) To Buy, Says Sell-Off Overdone
Mar 10, 2009 10:06 AM Citi Maintains a 'Buy' on The Medicines Company (MDCO), Adds to "Top Picks Live" List
Mar 3, 2009 08:36 AM Citi Maintains a 'Buy' on The Medicines Company (MDCO), Removes From Top Picks Live List
Feb 19, 2009 08:51 AM Citi Maintains a 'Buy' on The Medicines Company (MDCO), Adds Stock to Top Picks Live List
Jan 12, 2009 02:36 PM ARGUS Downgrades The Medicines Co. (MDCO) to Hold
Jan 8, 2009 10:28 AM Citi Top Biotech Ideas for 2009 (ALTH, MDCO)
May 29, 2008 09:01 AM Matrix USA Rating Changes 5/29
Feb 14, 2008 08:15 AM Citi Upgrades The Medicines Company (MDCO) to Buy
Oct 2, 2007 06:45 AM UBS upgrades Medicines Co. (MDCO) to Buy
Jul 20, 2007 08:31 AM RBC Capital upgradesMedicines Co. (MDCO) to Sector Perform
Apr 30, 2007 08:01 AM RBC Capital downgrades The Medicines (MDCO) to Underperform
Pages: 1 2 »» Last Page

Back to MDCO Stock Lookup